Abstract

For decades, research into cancer biology focused on the involvement of protein-coding genes. Only recently was it discovered that an entire class of molecules, termed non-coding RNA (ncRNA), plays key regulatory roles in shaping cellular activity. An explosion of studies into ncRNA biology has since shown that they represent a diverse and prevalent group of RNAs, including both oncogenic molecules and those that work in a tumor suppressive manner. As a result, hundreds of cancer-focused clinical trials involving ncRNAs as novel biomarkers or therapies have begun and these are likely just the beginning.

Keywords

BiologyComputational biologyCoding (social sciences)Long non-coding RNAMolecular oncologyGeneticsRNACancerGeneCarcinogenesis

MeSH Terms

BiomarkersTumorClinical Trials as TopicHumansMedical OncologyNeoplasmsOncogenesRNAUntranslated

Affiliated Institutions

Related Publications

Publication Info

Year
2019
Type
review
Volume
179
Issue
5
Pages
1033-1055
Citations
1612
Access
Closed

Social Impact

Altmetric

Social media, news, blog, policy document mentions

Citation Metrics

1612
OpenAlex
30
Influential
1311
CrossRef

Cite This

Frank J. Slack, Arul M. Chinnaiyan (2019). The Role of Non-coding RNAs in Oncology. Cell , 179 (5) , 1033-1055. https://doi.org/10.1016/j.cell.2019.10.017

Identifiers

DOI
10.1016/j.cell.2019.10.017
PMID
31730848
PMCID
PMC7347159

Data Quality

Data completeness: 90%